Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-09

Clinical Trial Update: High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating high dose atorvastatin to prevent periprocedural ischemic brain damage during carotid artery stenting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin (atorvastatin)

Snippet

Sponsor: Beijing Hospital | Conditions: Carotid Artery Stenosis | Phase 4 | Status: UNKNOWN